Bushu制药公司因质量、交付和可持续性优异而获2024年APAC奖。 
Bushu Pharmaceuticals wins 2024 APAC award for excellence in quality, delivery, and sustainability.
Bushu制药公司获得Frost & Sullivan颁发的2024年APAC客户价值领导奖,奖项是Frost & Sullivan奖,表彰制药制造业在质量保证、及时交货、可持续性和成本效益方面的杰出成就。 Bushu Pharmaceuticals has been awarded the 2024 APAC Customer Value Leadership Award by Frost & Sullivan for excelling in quality assurance, timely delivery, sustainability, and cost efficiency in the pharmaceutical manufacturing industry. 该公司在56个国家开展业务,专门从事从产品开发到供应链管理等各种服务,帮助95多个客户,其中半数来自国外。 The company, with operations in 56 countries, specializes in services ranging from product development to supply chain management, aiding over 95 clients, half of whom are from abroad. Bushu Pharma的创新服务和战略伙伴关系简化了市场进入,并提高了医疗保健的可及性。 Bushu Pharma's innovative services and strategic partnerships streamline market entry and enhance healthcare accessibility.
